Trademark: 98161602
Word
GVOKE VIALDX
Status
Pending
Status Code
686
Status Date
Tuesday, June 11, 2024
Serial Number
98161602
Mark Type
4
Filing Date
Friday, September 1, 2023
Published for Opposition
Tuesday, June 11, 2024

Trademark Owner History
Xeris Pharmaceuticals, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for in vivo diagnostic use; pharmaceutical preparations for diagnostic radiology use
44 Providing information relating to diagnostic properties of pharmaceuticals
GVOKE VIAL DX; G VOKE VIAL DX

Trademark Events
Sep 5, 2023
New Application Entered
Sep 27, 2023
New Application Office Supplied Data Entered
Apr 30, 2024
Assigned To Examiner
May 3, 2024
Approved For Pub - Principal Register
May 3, 2024
Examiners Amendment -Written
May 3, 2024
Examiners Amendment E-Mailed
May 3, 2024
Notification Of Examiners Amendment E-Mailed
May 3, 2024
Examiner's Amendment Entered
May 22, 2024
Notification Of Notice Of Publication E-Mailed
Jun 11, 2024
Published For Opposition
Jun 11, 2024
Official Gazette Publication Confirmation E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24